We can now choose our baby’s genes. Should we?

First you choose a partner, then you choose a genome? For this episode of FC Explains, Fast Company Senior Writer Ainsley Harris digs into the rapidly growing world of embryo genetic screening, including IVF startups like Orchid and Nucleus that offer parents the ability to select embryos based on genome sequencing.

Proponents say this kind of genetic testing helps optimize health outcomes and prevent hereditary disease. Parents say it’s giving their kids the best shot at life. On this episode of FC Explains we dig into why some scientists have called polygenic embryo screening “modern snake oil,” and why others are calling for an urgent, society-wide conversation about so-called “designer babies.” .

View the full article